pdufa.bio
CalendarConferencesAdCommDecisionsReadoutsResearchAccount
Home › PDUFA Calendar › JAZZ

JAZZ FDA calendar & decision history

Jazz Pharmaceuticals plc · 1 upcoming · 2 past FDA decisions

Upcoming FDA catalysts

JAZZ · Aug 25, 2026Ziihera (zanidatamab-hrii) - (HERIZON-GEA-01) — First-line HER2-positive gastroesophageal adenocarcinoma (GEA)

FDA decision history (2)

Oct 2, 2025✓ ApprovedFDA decisionAug 6, 2025✓ ApprovedFDA decision
Full PDUFA calendar →All FDA decisions →Phase readouts →
See the full 2026 PDUFA calendar →

This page aggregates JAZZ's FDA catalysts from pdufa.bio's own calendar and decision archive. Each item links to its source page. Facts and dates only; verify against primary FDA / SEC / company filings.